204 related articles for article (PubMed ID: 30477196)
1. De-Ritis Ratio Improves Long-Term Risk Prediction after Acute Myocardial Infarction.
Steininger M; Winter MP; Reiberger T; Koller L; El-Hamid F; Forster S; Schnaubelt S; Hengstenberg C; Distelmaier K; Goliasch G; Wojta J; Toma A; Niessner A; Sulzgruber P
J Clin Med; 2018 Nov; 7(12):. PubMed ID: 30477196
[TBL] [Abstract][Full Text] [Related]
2. Association of De Ritis Ratio with Prognosis in Patients with Coronary Artery Disease and Aminotransferase Activity within and outside the Healthy Values of Reference Range.
Ndrepepa G; Cassese S; Scalamogna M; Lahu S; Aytekin A; Xhepa E; Schunkert H; Kastrati A
J Clin Med; 2023 Apr; 12(9):. PubMed ID: 37176615
[TBL] [Abstract][Full Text] [Related]
3. The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients.
Wang H; Fang K; Zhang J; Jiang Y; Wang G; Zhang H; Chen T; Shi X; Li Y; Duan F; Liu J
Int Urol Nephrol; 2017 Aug; 49(8):1391-1398. PubMed ID: 28550473
[TBL] [Abstract][Full Text] [Related]
4. The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients.
Zinellu A; Arru F; De Vito A; Sassu A; Valdes G; Scano V; Zinellu E; Perra R; Madeddu G; Carru C; Pirina P; Mangoni AA; Babudieri S; Fois AG
Eur J Clin Invest; 2021 Jan; 51(1):e13427. PubMed ID: 33043447
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of De Ritis ratio in patients with acute myocardial infarction.
Ndrepepa G; Holdenrieder S; Kastrati A
Clin Chim Acta; 2022 Oct; 535():75-81. PubMed ID: 35985502
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of De Ritis ratio with aspartate aminotransferase and alanine aminotransferase within the reference range.
Ndrepepa G; Holdenrieder S; Kastrati A
Clin Chim Acta; 2023 Jan; 538():46-52. PubMed ID: 36370837
[TBL] [Abstract][Full Text] [Related]
7. The Prognosis Role of AST/ALT (De Ritis) Ratio in Patients with Adult Secondary Hemophagocytic Lymphohistiocytosis.
Yin G; Man C; Liao S; Qiu H
Mediators Inflamm; 2020; 2020():5719751. PubMed ID: 33376452
[TBL] [Abstract][Full Text] [Related]
8. Aspartate transaminase/alanine transaminase (De Ritis ratio) predicts survival in major burn patients.
Wang B; Hu L; Chen Y; Zhu B; Kong W; Zhu Z; Wang K; Yu Q; Zhang W; Wu G; Sun Y; Xia Z
Burns; 2022 Jun; 48(4):872-879. PubMed ID: 34456097
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy.
Gorgel SN; Kose O; Koc EM; Ates E; Akin Y; Yilmaz Y
Int Urol Nephrol; 2017 Sep; 49(9):1577-1583. PubMed ID: 28669104
[TBL] [Abstract][Full Text] [Related]
10. The Elevated De Ritis Ratio on Admission Is Independently Associated with Mortality in COVID-19 Patients.
Drácz B; Czompa D; Müllner K; Hagymási K; Miheller P; Székely H; Papp V; Horváth M; Hritz I; Szijártó A; Werling K
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366457
[TBL] [Abstract][Full Text] [Related]
11. De Ritis Ratio (AST/ALT) as a Significant Prognostic Factor in Patients With Upper Tract Urothelial Cancer Treated With Surgery.
Lee H; Choi YH; Sung HH; Han DH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Lee HM; Choi HY
Clin Genitourin Cancer; 2017 Jun; 15(3):e379-e385. PubMed ID: 27692696
[TBL] [Abstract][Full Text] [Related]
12. The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma.
Cho YH; Hwang JE; Chung HS; Kim MS; Hwang EC; Jung SI; Kang TW; Kwon DD; Choi SH; Kim HT; Kim TH; Kwon TG; Noh JH; Kim MK; Kim CS; Kang SG; Kang SH; Cheon J; Lee CH; Ku JY; Ha HK; Tae BS; Jeong CW; Ku JH; Kwak C; Kim HH
Int Urol Nephrol; 2017 Aug; 49(8):1383-1390. PubMed ID: 28484945
[TBL] [Abstract][Full Text] [Related]
13. Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy.
Ha YS; Kim SW; Chun SY; Chung JW; Choi SH; Lee JN; Kim BS; Kim HT; Yoo ES; Kwon TG; Kim WT; Kim WJ; Kim TH
BMC Urol; 2019 Jan; 19(1):10. PubMed ID: 30678673
[TBL] [Abstract][Full Text] [Related]
14. The reversed De Ritis ratio for predicting in-hospital mortality among intensive care patients with organophosphate poisoning.
Nafea O; Ibrahim F; Abdelhamid W
Biomarkers; 2023 Feb; 28(1):111-117. PubMed ID: 36377078
[TBL] [Abstract][Full Text] [Related]
15. De Ritis (aspartate transaminase/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy.
Nishikawa M; Miyake H; Fujisawa M
Urol Oncol; 2016 Sep; 34(9):417.e9-417.e15. PubMed ID: 27180325
[TBL] [Abstract][Full Text] [Related]
16. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [
Ruhwedel T; Rogasch JMM; Huang K; Jann H; Schatka I; Furth C; Amthauer H; Wetz C
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562643
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment Aspartate Aminotransferase-to-Alanine Aminotransferase (De Ritis) Ratio Predicts the Prognosis of Nonmetastatic Nasopharyngeal Carcinoma.
Wu J; Li S; Wang Y; Hu L
Onco Targets Ther; 2019; 12():10077-10087. PubMed ID: 31819502
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of De Ritis (AST/ALT) ratio in patients after surgery for urothelial carcinoma: a systematic review and meta-analysis.
Hu X; Yang WX; Wang Y; Shao YX; Xiong SC; Li X
Cancer Cell Int; 2020; 20():39. PubMed ID: 32042266
[TBL] [Abstract][Full Text] [Related]
20. De Ritis ratio and long-term major cardiovascular adverse events in patients undergoing elective percutaneous coronary intervention.
Ndrepepa G; Holdenrieder S; Kastrati A
Eur J Clin Invest; 2023 May; 53(5):e13942. PubMed ID: 36575818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]